loadpatents
name:-0.022240877151489
name:-0.018036842346191
name:-0.00043296813964844
Schafer; Hans Ludwig Patent Filings

Schafer; Hans Ludwig

Patent Applications and Registrations

Patent applications and USPTO patent grants for Schafer; Hans Ludwig.The latest application filed is for "methods for inhibiting atherosclerosis by administering an inhibitor of pcsk9".

Company Profile
0.17.17
  • Schafer; Hans Ludwig - Frankfurt am Main DE
  • Schafer; Hans-Ludwig - Hochheim DE
  • Schafer; Hans-Ludwig - Mainz-Kastel DE
  • Schafer; Hans-Ludwig - Erbach-Ernsbach DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods for inhibiting atherosclerosis by administering an anti-PCSK9 antibody
Grant 10,995,150 - Sasiela , et al. May 4, 2
2021-05-04
Methods For Inhibiting Atherosclerosis By Administering An Inhibitor Of Pcsk9
App 20200071422 - Sasiela; William J. ;   et al.
2020-03-05
Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9
Grant 10,494,442 - Sasiela , et al. De
2019-12-03
Novel Diphenylazetidinones, Process For Their Preparation, Medicaments Comprising These Compounds And Their Use
App 20100160282 - Glombik; Heiner ;   et al.
2010-06-24
Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
Grant 7,674,773 - Glombik , et al. March 9, 2
2010-03-09
Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
Grant 7,576,200 - Glombik , et al. August 18, 2
2009-08-18
Use Of Inhibitors Of The Cellular Na+/h+ Exchanger (nhe) For Preparing A Medicament For Normalizing Serum Lipids
App 20090143473 - LANG; Hans Jochen ;   et al.
2009-06-04
Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
Grant 7,488,829 - Glombik , et al. February 10, 2
2009-02-10
Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
App 20080281092 - Glombik; Heiner ;   et al.
2008-11-13
Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmceuticals
Grant 7,399,777 - Glombik , et al. July 15, 2
2008-07-15
Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
App 20070208179 - Glombik; Heiner ;   et al.
2007-09-06
Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
Grant 6,992,067 - Glombik , et al. January 31, 2
2006-01-31
Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
App 20050267038 - Glombik, Heiner ;   et al.
2005-12-01
Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
App 20050267177 - Glombik, Heiner ;   et al.
2005-12-01
Method of treatment with combinations of statin and aryl-substituted propanolamine derivatives
Grant 6,897,198 - Frick , et al. May 24, 2
2005-05-24
Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
Grant 6,884,812 - Glombik , et al. April 26, 2
2005-04-26
Use of inhibitors of the cellular Na+/H+ exchanger (NHE) for preparing a medicament for normalizing serum lipids
App 20040122096 - Lang, Hans Jochen ;   et al.
2004-06-24
Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
App 20040122069 - Glombik, Heiner ;   et al.
2004-06-24
Methods of treatment with combinations of statin and aryl-substituted propanolamine derivatives
App 20030195145 - Frick, Wendelin ;   et al.
2003-10-16
Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
Grant 6,624,185 - Glombik , et al. September 23, 2
2003-09-23
Combination product of a 1,4-benzothiepine 1,1-dioxide compound with at least on
App 20030158119 - Glombik, Heiner ;   et al.
2003-08-21
Combination product of an aryl-substituted propanolamine derivative with at least one other active ingredient and the use of the product
App 20030158094 - Glombik, Heiner ;   et al.
2003-08-21
Diarylcycloalkyl derivatives, processes for their preparation and their use s pharmaceuticals
App 20030144332 - Glombik, Heiner ;   et al.
2003-07-31
Combinations with statin and aryl-substituted propanolamine derivatives, their preparation pharmaceuticals comprising them, and their use
Grant 6,569,835 - Frick , et al. May 27, 2
2003-05-27
Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use
Grant 6,566,340 - Frick , et al. May 20, 2
2003-05-20
Combinations with statin and aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use
App 20020177610 - Frick, Wendelin ;   et al.
2002-11-28
Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
App 20020137689 - Glombik, Heiner ;   et al.
2002-09-26
Substituted acylguanidines, process for their preparation, their use as medicaments or diagnostics, and medicaments comprising them
Grant 6,451,781 - Kleemann , et al. September 17, 2
2002-09-17
Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use
App 20020128252 - Glombik, Heiner ;   et al.
2002-09-12
Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use
App 20020042381 - Frick, Wendelin ;   et al.
2002-04-11
1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar residues, process for their preparation, pharmaceuticals comprising these compounds, and their use
Grant 6,277,831 - Frick , et al. August 21, 2
2001-08-21
Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use
Grant 6,245,744 - Frick , et al. June 12, 2
2001-06-12
Compounds for treating disorders of lipid metabolism and their preparation
Grant 5,939,424 - Boger , et al. August 17, 1
1999-08-17
Medicament for the treatment of hyperlipidaemia and/or atherosclerosis
Grant 5,434,141 - Schafer , et al. July 18, 1
1995-07-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed